Cardiac Remodeling, Adaptations and Associated Myocardial Mechanics in Hypertensive Heart Diseases

Yau-Huei Lai1, Chi-In Lo1, Yih-Jer Wu2

  • 1Division of Cardiology, Department of Internal Medicine, Mackay Memorial Hospital; ; Department of Medicine, Mackay Medical College, and Mackay Medicine Nursing and Management College, Taipei;

Insights

Hypertension can cause early heart muscle dysfunction, detectable through myocardial deformation imaging. Recognizing this subclinical systolic dysfunction aids timely therapeutic intervention.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Physiology

Background:

  • Hypertension is a primary cause of heart failure and cardiovascular issues.
  • Left ventricular remodeling and diastolic dysfunction occur before overt heart failure.
  • Keywords: Concentric remodeling, Hypertension, Myocardial mechanics, Strain, Subclinical systolic dysfunction.

Purpose of the Study:

  • To explore early detection of myocardial contractile dysfunction using novel imaging techniques.
  • To understand cardiac systolic mechanics in early-stage hypertensive heart disease.

Main Methods:

  • Utilizing myocardial deformation imaging to quantify systolic strain and strain rate.
  • Analyzing longitudinal, circumferential, and radial strain patterns.

Main Results:

  • Longitudinal function is the most sensitive indicator of hypertension-related myocardial dysfunction, especially with left ventricular hypertrophy.
  • Circumferential and radial strains may compensate for longitudinal decline, preserving ejection fraction.
  • Early subclinical systolic dysfunction and compensatory mechanisms were identified.

Conclusions:

  • Myocardial deformation imaging enables early recognition of subclinical systolic dysfunction in hypertension.
  • Identifying this stage is crucial for effective therapeutic interventions.
  • Understanding mechanical compensation provides insights into hypertensive heart disease progression.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
733